LSE:GSKPharmaceuticals
GSK (LSE:GSK) Valuation Check After Strong 1 Year Shareholder Return
GSK (LSE:GSK) is back in focus after recent share price moves, with returns over the month, past 3 months and year giving investors fresh context for assessing this large UK pharmaceuticals group.
See our latest analysis for GSK.
At a latest share price of £18.58, GSK’s recent 90-day share price return of 14.13% sits alongside a 1-year total shareholder return of 49.96%, which hints at changing momentum and shifting expectations around its pharmaceuticals and vaccines portfolio.
If GSK’s move...